Personal information

Other IDs

SciProfiles: 1999737

Activities

Collapse all

Employment (1)

The First Affiliated Hospital of Nanchang University: Nanchang, CN

2020-07 to present
Employment
Source: Self-asserted source
Zhu Lizhen

Education and qualifications (2)

Zhejiang University: Hangzhou, Zhejiang, CN

2013 to 2020
Qualification
Source: Self-asserted source
Zhu Lizhen

German Cancer Research Center: Heidelberg, DE

2018 to 2019
Qualification
Source: Self-asserted source
Zhu Lizhen

Works (9)

Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer

Cancers
2022-01-28 | Journal article
DOI: 10.3390/cancers14030670
Contributors: Lizhen Zhu; Beiping Miao; Dagmara Dymerska; Magdalena Kuswik; Elena Bueno-Martínez; Lara Sanoguera-Miralles; Eladio A. Velasco; Nagarajan Paramasivam; Matthias Schlesner; Abhishek Kumar et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer

2021-12-22 | Preprint
DOI: 10.20944/preprints202112.0354.v1
Contributors: Lizhen Zhu; Beiping Miao; Dagmara Dymerska; Magdalena Kuświk; Elena Bueno-Martínez; Lara Sanoguera-Miralles; Eladio A. Velasco; Nagarajan Paramasivam; Matthias Schlesner; Abhishek Kumar et al.
Source: check_circle
Crossref

Identification and prognostic analysis of the cetuximab resistance-related gene <i>REV1</i> in <i>RAS</i> wild-type metastatic colorectal cancer.

American journal of cancer research
2021-06-15 | Journal article
PMID: 34249427
PMC: PMC8263679
Source: Self-asserted source
Zhu Lizhen

Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study.

Therapeutic advances in medical oncology
2021-06-14 | Journal article
DOI: 10.1177/17588359211023290
PMID: 34178123
PMC: PMC8207298
Source: Self-asserted source
Zhu Lizhen

Role of a Rare Variant in APC Gene Promoter 1B Region in Classic Familial Adenomatous Polyposis.

Digestion
2020-07-23 | Journal article
DOI: 10.1159/000509234
PMID: 32702694
Source: Self-asserted source
Zhu Lizhen

How should we correctly interpret biallelic germline truncating variant of MLH3 in hereditary colorectal cancer?

Genetics in Medicine
2019-11 | Journal article
DOI: 10.1038/s41436-019-0529-7
Contributors: Mengyuan Yang; Lizhen Zhu; Dong Xu; Shanshan Weng; Xuefeng Fang; Caixia Dong; Hanguang Hu; Ying Yuan
Source: check_circle
Crossref

A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer.

Journal of Cancer
2019-11-01 | Journal article
DOI: 10.7150/jca.27955
PMID: 31839814
PMC: PMC6909950
Source: Self-asserted source
Zhu Lizhen

A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.

The Journal of molecular diagnostics : JMD
2017-12-19 | Journal article
DOI: 10.1016/j.jmoldx.2017.11.007
PMID: 29277635
Source: Self-asserted source
Zhu Lizhen

A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.

OncoTargets and therapy
2016-08-08 | Journal article
DOI: 10.2147/ott.s107279
PMID: 27540301
PMC: PMC4982488
Source: Self-asserted source
Zhu Lizhen
How many people are using ORCID?